ER functions of oncogenes and tumor suppressors: Modulators of intracellular Ca2+ signaling

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1863, Issue 6, 2016, Pages 1364-1378

  Bittremieux, Mart ^a   Parys, Jan B ^a   Pinton, Paolo ^b   Bultynck, Geert ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Calcium; Cancer; Cell death; Endoplasmic reticulum; Oncogenes; Tumor suppressors

Indexed keywords

BECLIN 1; BRCA1 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN BAK; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BOK; PROTEIN KINASE B; PROTEIN MCL 1; PROTEIN P53; RAS PROTEIN; UNCLASSIFIED DRUG; CALCIUM; ONCOPROTEIN; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; AUTOPHAGY; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CANCER CELL; ENDOPLASMIC RETICULUM; HEMATOPOIETIC STEM CELL; HUMAN; LYMPHOCYTE; MITOCHONDRION; NERVE CELL; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; STEADY STATE; TUMOR SUPPRESSOR GENE; UPREGULATION; ANIMAL; BIOLOGICAL MODEL; CELL SURVIVAL; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CELL SURVIVAL; ENDOPLASMIC RETICULUM; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; ONCOGENE PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 84955515266     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2016.01.002     Document Type: Review

References (187)

1. Berridge M.J., Lipp P., Bootman M.D. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 2000, 1(1):11-21.
2. Berridge M.J., Bootman M.D., Roderick H.L. Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 2003, 4(7):517-529.
3. Pozzan T., Rizzuto R., Volpe P., Meldolesi J. Molecular and cellular physiology of intracellular calcium stores. Physiol. Rev. 1994, 74(3):595-636.
4. Clapham D.E. Calcium signaling. Cell 2007, 131(6):1047-1058.
5. Csordás G., Várnai P., Golenár T., Roy S., Purkins G., Schneider T.G., Balla T., Hajnóczky G. Imaging interorganelle contacts and local calcium dynamics at the ER-mitochondrial interface. Mol. Cell 2010, 39(1):121-132.
6. 2+ channels. Mol. Cell 2010, 38(2):280-290.
7. Prins D., Michalak M. Organellar calcium buffers. Cold Spring Harb. Perspect. Biol. 2011, 3(3):1-16.
8. 2+ pumps of the endoplasmic reticulum and Golgi apparatus. Cold Spring Harb. Perspect. Biol. 2011, 3(5).
9. 2+ release channels. Physiol. Rev. 2007, 87(2):593-658.
10. Parys J.B., De Smedt H. Inositol 1,4,5-trisphosphate and its receptors. Adv. Exp. Med. Biol. 2012, 740:255-279.
11. Fedorenko O.A., Popugaeva E., Enomoto M., Stathopulos P.B., Ikura M., Bezprozvanny I. Intracellular calcium channels: inositol-1,4,5-trisphosphate receptors. Eur. J. Pharmacol. 2014, 739:39-48.
12. 3- and calcium-gated channels from endoplasmic reticulum of cerebellum. Nature 1991, 351:751-754.
13. Finch E., Turner T., Goldin S. Calcium as a coagonist of inositol 1,4,5-trisphosphate-induced calcium release. Science 1991, 252:443-446.
14. 2+ release in smooth muscle cells of the guinea pig taenia caeci. J. Gen. Physiol. 1990, 95(6):1103-1122.
15. 3R) and its regulators: sometimes good and sometimes bad teamwork. Sci. STKE 2006, 1-12.
16. 2+ release by reversible phosphorylation and dephosphorylation. Biochim. Biophys. Acta, Mol. Cell Res. 2009, 1793(6):959-970.
17. Iino M. Effects of adenine nucleotides on inositol 1,4,5-trisphosphate-induced calcium release in vascular smooth muscle cells. J. Gen. Physiol. 1991, 98(4):681-698.
18. Bezprozvanny I., Ehrlich B.E. ATP modulates the function of inositol 1,4,5-trisphosphate-gated channels at two sites. Neuron 1993, 10(6):1175-1184.
19. Maes K., Missiaen L., De Smet P., Vanlingen S., Callewaert G., Parys J.B., De Smedt H. Differential modulation of inositol 1,4,5-trisphosphate receptor type 1 and type 3 by ATP. Cell Calcium 2000, 27(5):257-267.
20. 2+ release by type-2 and type-3 inositol (1,4,5)-triphosphate receptors: differing ATP sensitivities and molecular determinants of action. J. Biol. Chem. 2008, 283(31):21579-21587.
21. Marchi S., Patergnani S., Pinton P. The endoplasmic reticulum-mitochondria connection: one touch, multiple functions. Biochim. Biophys. Acta Bioenerg. 2014, 1837(4):461-469.
22. Rizzuto R., De Stefani D., Raffaello A., Mammucari C. Mitochondria as sensors and regulators of calcium signalling. Nat. Rev. Mol. Cell Biol. 2012, 13(9):566-578.
23. 2+ transfer from the ER to mitochondria: when, how and why. Biochim. Biophys. Acta Bioenerg. 2009, 1787(11):1342-1351.
24. Shoshan-Barmatz V., Gincel D. The voltage-dependent anion channel: characterization, modulation, and role in mitochondrial function in cell life and death. Cell Biochem. Biophys. 2003, 39(3):279-292.
25. Colombini M. VDAC structure, selectivity, and dynamics. Biochim. Biophys. Acta Biomembr. 2012, 1818(6):1457-1465.
26. Marchi S., Pinton P. The mitochondrial calcium uniporter complex: molecular components, structure and physiopathological implications. J. Physiol. 2014, 592(5):829-839.
27. 2+ channels. J. Cell Biol. 2006, 175(6):901-911.
28. van Vliet A.R., Verfaillie T., Agostinis P. New functions of mitochondria associated membranes in cellular signaling. Biochim. Biophys. Acta, Mol. Cell Res. 2014, 1843(10):2253-2262.
29. 2+ transfer to mitochondria. Cell 2010, 142(2):270-283.
30. Wiel C., Lallet-Daher H., Gitenay D., Gras B., Le Calvé B., Augert A., Ferrand M., Prevarskaya N., Simonnet H., Vindrieux D., Bernard D. Endoplasmic reticulum calcium release through ITPR2 channels leads to mitochondrial calcium accumulation and senescence. Nat. Commun. 2014, 5:3792-3793.
31. 2+ signals as causes or consequences of mitophagy induction. Autophagy 2013, 9(11):1677-1686.
32. 2+ signals in autophagy. Cell Calcium 2012, 52(1):44-51.
33. 3 receptor-mitochondria connection in apoptosis and autophagy. Biochim. Biophys. Acta, Mol. Cell Res. 2011, 1813(5):1003-1013.
34. Kaufman R.J., Malhotra J.D. Calcium trafficking integrates endoplasmic reticulum function with mitochondrial bioenergetics. Biochim. Biophys. Acta, Mol. Cell Res. 2014, 1843(10):2233-2239.
35. 2+ and apoptosis. Cell Calcium 2012, 52(1):36-43.
36. Morciano G., Giorgi C., Bonora M., Punzetti S., Pavasini R., Wieckowski M.R., Campo G., Pinton P. Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury. J. Mol. Cell. Cardiol. 2015, 78:142-153.
37. 2+ influx targets cardiolipin to disintegrate respiratory chain complex II for cell death induction. Cell Death Differ. 2014, 21(11):1-13.
38. 2+-release channel in autophagy. Cell Commun. Signal. 2012, 10(1):17.
39. Decuypere J.P., Parys J.B., Bultynck G. ITPRs/inositol 1,4,5-trisphosphate receptors in autophagy: from enemy to ally. Autophagy 2015, 11(10):1944-1948.
40. Kania E., Pajak B., Orzechowski A. Calcium homeostasis and ER stress in control of autophagy in cancer cells. Biomed Res. Int. 2015, 2015:1-12.
41. Sica V., Galluzzi L., Bravo-San Pedro J.M., Izzo V., Maiuri M.C., Kroemer G. Organelle-specific initiation of autophagy. Mol. Cell 2015, 59(4):522-539.
42. 2+ in autophagy regulation. Cell Calcium 2011, 50(3):242-250.
43. Høyer-Hansen M., Bastholm L., Szyniarowski P., Campanella M., Szabadkai G., Farkas T., Bianchi K., Fehrenbacher N., Elling F., Rizzuto R., Mathiasen I.S., Jäättelä M. Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-β, and Bcl-2. Mol. Cell 2007, 25(2):193-205.
44. Stewart T.A., Yapa K.T.D.S., Monteith G.R. Altered calcium signaling in cancer cells. Biochim. Biophys. Acta Biomembr. 2014, 1848(10):2502-2511.
45. Prevarskaya N., Skryma R., Shuba Y. Calcium in tumour metastasis: new roles for known actors. Nat. Rev. Cancer 2011, 11(8):609-618.
46. 2+ for cancer cell proliferation and survival. Nat. Rev. Cancer 2008, 8(5):361-375.
47. Monteith G.R., Davis F.M., Roberts-Thomson S.J. Calcium channels and pumps in cancer: changes and consequences. J. Biol. Chem. 2012, 287(38):31666-31673.
48. Marchi S., Giorgi C., Oparka M., Duszynski J., Wieckowski M.R., Pinton P. Oncogenic and oncosuppressive signal transduction at mitochondria-associated endoplasmic reticulum membranes. Mol. Cell. Oncol. 2014, 1(2).
49. Akl H., Vervloessem T., Kiviluoto S., Bittremieux M., Parys J.B., De Smedt H., Bultynck G. A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum. Biochim. Biophys. Acta, Mol. Cell Res. 2014, 1843(10):2240-2252.
50. Greenberg E.F., Lavik A.R., Distelhorst C.W. Bcl-2 regulation of the inositol 1,4,5-trisphosphate receptor and calcium signaling in normal and malignant lymphocytes: potential new target for cancer treatment. Biochim. Biophys. Acta, Mol. Cell Res. 2014, 1843(10):2205-2210.
51. Brunelle J.K., Letai A. Control of mitochondrial apoptosis by the Bcl-2 family. J. Cell Sci. 1993, 122(4):437-441.
52. Chipuk J.E., Moldoveanu T., Llambi F., Parsons M.J., Green D.R. The BCL-2 family reunion. Mol. Cell 2010, 37(3):299-310.
53. Szegezdi E., Macdonald D.C., Ní Chonghaile T., Gupta S., Samali A. Bcl-2 family on guard at the ER. Am. J. Physiol. Cell Physiol. 2009, 296(5):C941-C953.
54. Pegoraro L., Palumbo A., Erikson J., Falda M., Giovanazzo B., Emanuel B.S., Rovera G., Nowell P.C., Croce C.M. A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia. Proc. Natl. Acad. Sci. U. S. A. 1984, 81(22):7166-7170.
55. Tsujimoto Y., Finger L.R., Yunis J., Nowell P.C., Croce C.M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984, 226(4678):1097-1099.
56. Chen Q., Xu H., Xu A., Ross T., Bowler E., Hu Y., Lesnefsky E.J. Inhibition of Bcl-2 sensitizes mitochondrial permeability transition pore (MPTP) opening in ischemia-damaged mitochondria. PLoS One 2015, 10(3).
57. Moldoveanu T., Follis A.V., Kriwacki R.W., Green D.R. Many players in BCL-2 family affairs. Trends Biochem. Sci. 2014, 39(3):101-111.
58. Adachi M., Cossman J., Longo D., Croce C.M., Tsujimoto Y. Variant translocation of the bcl-2 gene to immunoglobulin lambda light chain gene in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 1989, 86(8):2771-2774.
59. Aisenberg A., Wilkes B., Jacobson J. The bcl-2 gene is rearranged in many diffuse B-cell lymphomas. Blood 1988, 71(4):969-972.
60. Daniel J.C., Smythe W.R. The role of bcl-2 family members in non-small cell lung cancer. Semin. Thorac. Cardiovasc. Surg. 2004, 16(1):19-27.
61. Tsujimoto Y., Cossman J., Jaffe E., Croce C.M. Involvement of the Bcl-2 gene in human follicular lymphoma. Science 1985, 228(4706):1440-1443.
62. Calin G.A., Pekarsky Y., Croce C.M. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Pract. Res. Clin. Haematol. 2007, 20(3):425-437.
63. Hanada M., Delia D., Aiello A., Stadtmauer E., Reed J.C. Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 1993, 82(6):1820-1828.
64. 2+ influx in Bcl-2-overexpressing cells. Cell 2000, 148(5):857-862.
65. 2+ concentration within the endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(11):5723-5728.
66. 2+ analyzed with an improved genetically encoded fluorescent sensor. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(50):17404-17409.
67. Schendel S.L., Xie Z., Montal M.O., Matsuyama S., Montal M., Reed J.C. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(10):5113-5118.
68. Oakes S.A., Scorrano L., Opferman J.T., Bassik M.C., Nishino M., Pozzan T., Korsmeyer S.J. Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(1):105-110.
69. 2+ signaling. J. Biol. Chem. 2010, 285(18):13678-13684.
70. 2+-ATPase (SERCA). Biochem. J. 2004, 383:361-370.
71. 2+ signaling, which do not depend on their putative pore-forming region. J. Biol. Chem. 2004, 279(52):54581-54589.
72. Erin N., Bronson S.K., Billingsley M.L. Calcium-dependent interaction of calcineurin with Bcl-2 in neuronal tissue. Neuroscience 2003, 117(3):541-555.
73. 3-mediated calcium release and apoptosis by Bcl-2 involves the participation of protein phosphatase 1. Mol. Cell. Biochem. 2007, 295(1-2):153-165.
74. Chang M.J., Zhong F., Lavik A.R., Parys J.B., Berridge M.J., Distelhorst C.W. Feedback regulation mediated by Bcl-2 and DARPP-32 regulates inositol 1,4,5-trisphosphate receptor phosphorylation and promotes cell survival. Proc. Natl. Acad. Sci. 2014, 111(3):1186-1191.
75. Wei Y., Sinha S., Levine B. Dual role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation. Autophagy 2008, 4(7):949-951.
76. 3R. Nat. Cell Biol. 2005, 7(10):1021-1028.
77. Li C., Wang X., Vais H., Thompson C.B., Foskett J.K., White C. Apoptosis regulation by Bcl-x(L) modulation of mammalian inositol 1,4,5-trisphosphate receptor channel isoform gating. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(30):12565-12570.
78. 2+-mediated apoptosis. Biochem. J. 2012, 444(1):127-139.
79. 2+ fluxes. Proc. Natl. Acad. Sci. U. S. A. 1994, 91(14):6569-6573.
80. Chen R., Valencia I., Zhong F., McColl K.S., Roderick H.L., Bootman M.D., Berridge M.J., Conway S.J., Holmes A.B., Mignery G.A., Velez P., Distelhorst C.W. Bcl-2 functionally interacts with inositol 1,4,5-trisphosphate receptors to regulate calcium release from the ER in response to inositol 1,4,5-trisphosphate. J. Cell Biol. 2004, 166(2):193-203.
81. 2+ uptake by mitochondria without affecting ER calcium store content. Cell Calcium 2008, 44(3):324-338.
82. 2+ signals according to the strength of T cell receptor activation. J. Cell Biol. 2006, 172(1):127-137.
83. 3 receptor. Proc. Natl. Acad. Sci. U. S. A. 2009, 106(34):14397-14402.
84. 2+ signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl. Cell Death Differ. 2012, 19(2):295-309.
85. 3 receptor. PLoS One 2013, 8(8).
86. 3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals. Mol. Cell 2008, 31(2):255-265.
87. 3 receptor interaction. Blood 2011, 117(10):2924-2934.
88. Akl H., Monaco G., La Rovere R., Welkenhuyzen K., Kiviluoto S., Vervliet T., Molgó J., Distelhorst C.W., Missiaen L., Mikoshiba K., Parys J.B., De Smedt H., Bultynck G. IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2. Cell Death Dis. 2013, 4:E632.
89. Lavik A., Zhong F., Chang M., Greenberg E., Choudhary Y., Smith M., McColl K., Pink J., Reu F., Matsuyama S., Distelhorst C. A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2. Oncotarget 2015, 6(29):27388-27402.
90. Greenberg E.F., McColl K.S., Zhong F., Wildey G., Dowlati A., Distelhorst C.W. Synergistic killing of human small cell lung cancer cells by the Bcl-2-inositol 1,4,5-trisphosphate receptor disruptor BIRD-2 and the BH3-mimetic ABT-263. Cell Death Dis. 2015, 6.
91. 3 receptor/Bcl-2 complexes. Int. J. Dev. Biol. 2015.
92. Distelhorst C.W., Shore G.C. Bcl-2 and calcium: controversy beneath the surface. Oncogene 2004, 23(16):2875-2880.
93. Xu Q., Reed J.C. Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol. Cell 1998, 1(3):337-346.
94. 2+-permeable channel pore. J. Biol. Chem. 2012, 287(4):2544-2557.
95. 2+ exchanger. Sci. Signal. 2014, 7(343).
96. Rojas-Rivera D., Hetz C. TMBIM protein family: ancestral regulators of cell death. Oncogene 2015, 34(3):269-280.
97. 2+ homeostasis downstream of Bcl-2 family proteins. J. Biol. Chem. 2008, 283(17):11477-11484.
98. Wang N.S., Unkila M.T., Reineks E.Z., Distelhorst C.W. Transient expression of wild-type or mitochondrially targeted Bcl-2 induces apoptosis, whereas transient expression of endoplasmic reticulum-targeted Bcl-2 is protective against Bax-induced cell death. J. Biol. Chem. 2001, 276(47):44117-44128.
99. Hanson C.J., Bootman M.D., Distelhorst C.W., Maraldi T., Roderick H.L. The cellular concentration of Bcl-2 determines its pro- or anti-apoptotic effect. Cell Calcium 2008, 44(3):243-258.
100. Vervliet T., Decrock E., Molgó J., Sorrentino V., Missiaen L., Leybaert L., De Smedt H., Kasri N.N., Parys J.B., Bultynck G. Bcl-2 binds to and inhibits ryanodine receptors. J. Cell Sci. 2014, 127:2782-2792.
101. Vervliet T., Parys J.B., Bultynck G. Bcl-2 and FKBP12 bind to IP3 and ryanodine receptors at overlapping sites: the complexity of protein-protein interactions for channel regulation. Biochem. Soc. Trans. 2015, 43(3):396-404.
102. Vervliet T., Lemmens I., Welkenhuyzen K., Tavernier J., Parys J.B., Bultynck G. Regulation of the ryanodine receptor by anti-apoptotic Bcl-2 is independent of its BH3-domain-binding properties. Biochem. Biophys. Res. Commun. 2015, 463(3):174-179.
103. Zhang L., Liu Y., Song F., Zheng H., Hu L., Lu H., Liu P., Hao X., Zhang W., Chen K. Functional SNP in the microRNA-367 binding site in the 3'UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification. Proc. Natl. Acad. Sci. 2011, 108(33):13653-13658.
104. Davis F.M., Parsonage M.T., Cabot P.J., Parat M.O., Thompson E.W., Roberts-Thomson S.J., Monteith G.R. Assessment of gene expression of intracellular calcium channels, pumps and exchangers with epidermal growth factor-induced epithelial-mesenchymal transition in a breast cancer cell line. Cancer Cell Int. 2013, 13(1):76-83.
105. Boise L.H., González-García M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nuñez G., Thompson C.B. Bcl-X, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993, 74(4):597-608.
106. Thomas S., Quinn B.A., Das S.K., Dash R., Emdad L., Dasgupta S., Wang X.Y., Dent P., Reed J.C., Pellecchia M., Sarkar D., Fisher P.B. Targeting the Bcl-2 family for cancer therapy. Expert Opin. Ther. Targets 2013, 17(1):61-75.
107. Zhang K., Jiao K., Xing Z., Zhang L., Yang J., Xie X., Yang L. Bcl-xL overexpression and its association with the progress of tongue carcinoma. Int. J. Clin. Exp. Pathol. 2014, 7(11):7360-7377.
108. Nagane M., Levitzki A., Gazit A., Cavenee W.K., Huang H.J. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(10):5724-5729.
109. Mason K.D., Carpinelli M.R., Fletcher J.I., Collinge J.E., Hilton A.A., Ellis S., Kelly P.N., Ekert P.G., Metcalf D., Roberts A.W., Huang D.C.S., Kile B.T. Programmed anuclear cell death delimits platelet life span. Cell 2007, 128(6):1173-1186.
110. Leverson J.D., Phillips D.C., Mitten M.J., Boghaert E.R., Diaz D., Tahir S.K., Belmont L.D., Nimmer P., Xiao Y., Ma X.M., Lowes K.N., Kovar P., Chen J., Jin S., Smith M., Xue J., Zhang H., Oleksijew A., Magoc T.J., Vaidya K.S., Albert D.H., Tarrant J.M., La N., Wang L., Tao Z.F., Wendt M.D., Sampath D., Rosenberg S.H., Tse C., Huang D.C.S., Fairbrother W.J., Elmore S.W., Souers A.J. Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy. Sci. Transl. Med. 2015, 7(279).
111. 2+ release channel BH3 domains. Biophys. J. 2009, 96:391-392.
112. Vervliet T., Lemmens I., Vandermarliere E., Decrock E., Ivanova H., Monaco G., Sorrentino V., Kasri N.N., Missiaen L., Martens L., De Smedt H., Leybaert L., Parys J.B., Tavernier J., Bultynck G. Ryanodine receptors are targeted by anti-apoptotic Bcl-XL involving its BH4 domain and Lys87 from its BH3 domain. Sci. Rep. 2015, 5:9641.
113. Shimizu S., Konishi A., Kodama T., Tsujimoto Y. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(7):3100-3105.
114. 2+ uptake. J. Biol. Chem. 2013, 288(27):19870-19881.
115. Arbel N., Ben-Hail D., Shoshan-Barmatz V. Mediation of the antiapoptotic activity of Bcl-xL protein upon interaction with VDAC1 protein. J. Biol. Chem. 2012, 287(27):23152-23161.
116. 2+ signals to mitochondria. J. Biol. Chem. 2015, 290(14):9150-9161.
117. Shoshan-Barmatz V., Ben-Hail D., Admoni L., Krelin Y., Tripathi S.S. The mitochondrial voltage-dependent anion channel 1 in tumor cells. Biochim. Biophys. Acta 2015, 1848(10):2547-2575.
118. Opferman J.T., Letai A., Beard C., Sorcinelli M.D., Ong C.C., Korsmeyer S.J. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 2003, 426:671-676.
119. Dzhagalov I., Dunkle A., He Y.W. The anti-apoptotic Bcl-2 family member Mcl-1 promotes T lymphocyte survival at multiple stages. J. Immunol. 2008, 181(1):521-528.
120. Arbour N., Vanderluit J.L., Le Grand J.N., Jahani-Asl A., Ruzhynsky V.A., Cheung E.C.C., Kelly M.A., MacKenzie A.E., Park D.S., Opferman J.T., Slack R.S. Mcl-1 is a key regulator of apoptosis during CNS development and after DNA damage. J. Neurosci. 2008, 28(24):6068-6078.
121. Opferman J.T., Iwasaki H., Ong C.C., Suh H., Mizuno S., Akashi K., Korsmeyer S.J. Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 2005, 307:1101-1104.
122. Rinkenberger J.L., Horning S., Klocke B., Roth K., Korsmeyer S.J. Mcl-1 deficiency results in peri-implantation embryonic lethality. Genes Dev. 2000, 14(1):23-27.
123. Akgul C. Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell. Mol. Life Sci. 2009, 66(8):1326-1336.
124. Beroukhim R., Mermel C.H., Porter D., Wei G., Raychaudhuri S., Donovan J., Barretina J., Boehm J.S., Dobson J., Urashima M., Mc Henry K.T., Pinchback R.M., Ligon A.H., Cho Y., Haery L., Greulich H., Reich M., Winckler W., Lawrence M.S., Weir B.A., Tanaka K.E., Chiang D.Y., Bass A.J., Loo A., Hoffman C., Prensner J., Liefeld T., Gao Q., Yecies D., Signoretti S., Maher E., Kaye F.J., Sasaki H., Tepper J.E., Fletcher J.A., Tabernero J., Baselga J., Tsao M.S., Demichelis F., Rubin M.A., Janne P.A., Daly M.J., Nucera C., Levine R.L., Ebert B.L., Gabriel S., Rustgi A.K., Antonescu C.R., Ladanyi M., Letai A., Garraway L.A., Loda M., Beer D.G., True L.D., Okamoto A., Pomeroy S.L., Singer S., Golub T.R., Lander E.S., Getz G., Sellers W.R., Meyerson M. The landscape of somatic copy-number alteration across human cancers. Nature 2010, 463(7293):899-905.
125. Belmar J., Fesik S.W. Small molecule Mcl-1 inhibitors for the treatment of cancer. Pharmacol. Ther. 2015, 145:76-84.
126. 2+ uptake and reactive oxygen species generation. Cell Death Dis. 2014, 5.
127. Morciano G., Giorgi C., Balestra D., Marchi S., Pinotti M., Pinton P. Mcl-1 involvement in mitochondrial dynamics is associated with apoptotic cell death. Mol. Biol. Cell 2016, 27:20-34.
128. Hsu S.Y., Kaipia A., McGee E., Lomeli M., Hsueh A.J. Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proc. Natl. Acad. Sci. U. S. A. 1997, 94(23):12401-12406.
129. Ke F., Voss A., Kerr J.B., O'Reilly L., Tai L., Echeverry N., Bouillet P., Strasser A., Kaufmann T. BCL-2 family member BOK is widely expressed but its loss has only minimal impact in mice. Cell Death Differ. 2012, 19(6):915-925.
130. Echeverry N., Bachmann D., Ke F., Strasser A., Simon H.U., Kaufmann T. Intracellular localization of the BCL-2 family member BOK and functional implications. Cell Death Differ. 2013, 20(6):785-799.
131. Lippincott-Schwartz J., Yuan L.C., Bonifacino J.S., Klausner R.D. Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: evidence for membrane cycling from Golgi to ER. Cell 1989, 56(5):801-813.
132. Carpio M.A., Michaud M., Zhou W., Fisher J.K., Walensky L.D., Katz S.G. BCL-2 family member BOK promotes apoptosis in response to endoplasmic reticulum stress. Proc. Natl. Acad. Sci. 2015, 112(23):7201-7206.
133. Schulman J.J., Wright F.A., Kaufmann T., Wojcikiewicz R.J.H. The Bcl-2 protein family member bok binds to the coupling domain of inositol 1,4,5-trisphosphate receptors and protects them from proteolytic cleavage. J. Biol. Chem. 2013, 288(35):25340-25349.
134. Hirota J., Furuichi T., Mikoshiba K. Inositol 1,4,5-trisphosphate receptor type 1 is a substrate for caspase-3 and is cleaved during apoptosis in a caspase-3-dependent manner. J. Biol. Chem. 1999, 274(48):34433-34437.
135. Assefa Z., Bultynck G., Szlufcik K., Nadif Kasri N., Vermassen E., Goris J., Missiaen L., Callewaert G., Parys J.B., De Smedt H. Caspase-3-induced truncation of type 1 inositol trisphosphate receptor accelerates apoptotic cell death and induces inositol trisphosphate-independent calcium release during apoptosis. J. Biol. Chem. 2004, 279(41):43227-43236.
136. 2+ signalling. Biol. Cell. 2008, 100(1):39-49.
137. 2+ homeostasis and developmental competence of mouse oocytes and eggs. J. Cell. Physiol. 2014, 229(11):1842-1854.
138. Elkoreh G., Blais V., Béliveau É., Guillemette G., Denault J.B. Type 1 inositol-1,4,5-trisphosphate receptor is a late substrate of caspases during apoptosis. J. Cell. Biochem. 2012, 113(8):2775-2784.
139. Akimzhanov A.M., Barral J.M., Boehning D. Caspase 3 cleavage of the inositol 1,4,5-trisphosphate receptor does not contribute to apoptotic calcium release. Cell Calcium 2013, 53(2):152-158.
140. Fu L.L., Cheng Y., Liu B. Beclin-1: autophagic regulator and therapeutic target in cancer. Int. J. Biochem. Cell Biol. 2013, 45(5):921-924.
141. Toton E., Lisiak N., Sawicka P., Rybczynska M. Beclin-1 and its role as a target for anticancer therapy. J. Physiol. Pharmacol. 2014, 64(4):459-467.
142. Kang R., Zeh H.J., Lotze M.T., Tang D. The beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011, 18(4):571-580.
143. Decuypere J.P., Parys J.B., Bultynck G. Regulation of the autophagic bcl-2/beclin 1 interaction. Cells 2012, 1(3):284-312.
144. Turcotte S., Giaccia A.J. Targeting cancer cells through autophagy for anticancer therapy. Curr. Opin. Cell Biol. 2010, 22(2):246-251.
145. 2+ signaling and autophagy induction are interrelated. Autophagy 2011, 7(12):1472-1489.
146. Vicencio J.M., Ortiz C., Criollo A., Jones A.W.E., Kepp O., Galluzzi L., Joza N., Vitale I., Morselli E., Tailler M., Castedo M., Maiuri M.C., Molgó J., Szabadkai G., Lavandero S., Kroemer G. The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell Death Differ. 2009, 16(7):1006-1017.
147. Hemmings B.A., Restuccia D.F. PI3K-PKB/Akt pathway. Cold Spring Harb. Perspect. Biol. 2012, 4(9).
148. Worby C.A., Dixon J.E. PTEN. Annu. Rev. Biochem. 2014, 83(1):641-669.
149. Milella M., Falcone I., Conciatori F., Cesta Incani U., Del Curatolo A., Inzerilli N., Nuzzo C.M.A., Vaccaro V., Vari S., Cognetti F., Ciuffreda L. PTEN: multiple functions in human malignant tumors. Front. Oncol. 2015, 5:1-14.
150. Martini M., De Santis M.C., Braccini L., Gulluni F., Hirsch E. PI3K/AKT signaling pathway and cancer: an updated review. Ann. Med. 2014, 34:1-12.
151. Khan M.T., Wagner L., Yule D.I., Bhanumathy C., Joseph S.K. Akt kinase phosphorylation of inositol 1,4,5-trisphosphate receptors. J. Biol. Chem. 2006, 281(6):3731-3737.
152. 2+ release and apoptosis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(7):2427-2432.
153. 2+-dependent apoptotic stimuli. Biochem. Biophys. Res. Commun. 2008, 375(4):501-505.
154. 2+ release and apoptosis. Cell Death Dis. 2012, 3(5):e304.
155. Hotchkiss R.S., Strasser A., Mcdunn J.E., Swanson P.E. Type 3 inositol 1,4,5-trisphosphate receptor modulates cell death. FASEB J. 2000, 14(10):1375-1379.
156. Mendes C.C.P., Gomes D.A., Thompson M., Souto N.C., Goes T.S., Goes A.M., Rodrigues M.A., Gomez M.V., Nathanson M.H., Leite M.F. The type III inositol 1,4,5-trisphosphate receptor preferentially transmits apoptotic Ca2 + signals into mitochondria. J. Biol. Chem. 2005, 280(49):40892-40900.
157. Jayaraman T., Marks A.R. T cells deficient in inositol 1,4,5-trisphosphate receptor are resistant to apoptosis. Mol. Cell. Biol. 1997, 17(6):3005-3012.
158. 2+ signaling and apoptosis in a protein phosphatase-dependent manner. Cell Death Differ. 2013, 20(12):1631-1643.
159. Salomoni P., Pandolfi P.P. The role of PML in tumor suppression. Cell 2002, 108:165-170.
160. Salomoni P., Ferguson B., Wyllie A., Rich T. New insights into the role of PML in tumour suppression. Cell Res. 2008, 18:622-640.
161. Pinton P., Giorgi C., Pandolfi P.P. The role of PML in the control of apoptotic cell fate: a new key player at ER-mitochondria sites. Cell Death Differ. 2011, 18:1450-1456.
162. Bernardi R., Papa A., Pandolfi P.P. Regulation of apoptosis by PML and the PML-NBs. Oncogene 2008, 27:6299-6312.
163. Giorgi C., Ito K., Lin H., Santangelo C., Wieckowski M.R., Lebiedzinska M., Bononi A., Bonora M., Duszynski J., Bernardi R., Rizzuto R., Tacchetti C., Pinton P., Pandolfi P.P. PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science 2010, 330:1247-1251.
164. Silver D.P., Livingston D.M. Mechanisms of BRCA1 tumor suppression. Cancer Discov. 2012, 2:679-684.
165. Elia A.E., Elledge S.J. BRCA1 as tumor suppressor: lord without its RING?. Breast Cancer Res. 2012, 14(2):306.
166. Makharashvili N., Paull T.T. CtIP: a DNA damage response protein at the intersection of DNA metabolism. DNA Repair (Amst) 2015, 32:75-81.
167. Castillo A., Paul A., Sun B., Huang T.H., Wang Y., Yazinski S.A., Tyler J., Li L., You M.J., Zou L., Yao J., Wang B. The BRCA1-interacting protein Abraxas is required for genomic stability and tumor suppression. Cell Rep. 2014, 8(3):807-817.
168. Cantor S.B., Guillemette S. Hereditary breast cancer and the BRCA1-associated FANCJ/BACH1/BRIP1. Future Oncol. 2011, 7(2):253-261.
169. Hedgepeth S.C., Garcia M.I., Wagner L.E., Rodriguez A.M., Chintapalli S.V., Snyder R.R., Hankins G.D.V., Henderson B.R., Brodie K.M., Yule D.I., van Rossum D.B., Boehning D. The BRCA1 tumor suppressor binds to inositol 1,4,5-trisphosphate receptors to stimulate apoptotic calcium release. J. Biol. Chem. 2015, 290(11):7304-7313.
170. Liu J., Zhang C., Feng Z. Tumor suppressor p53 and its gain-of-function mutants in cancer. Acta Biochim. Biophys. Sin. (Shanghai) 2014, 46(3):170-179.
171. Liu J., Zhang C., Hu W., Feng Z. Tumor suppressor p53 and its mutants in cancer metabolism. Cancer Lett. 2015, 356(2):197-203.
172. Duffy M.J., Synnott N.C., McGowan P.M., Crown J., O'Connor D., Gallagher W.M. P53 as a target for the treatment of cancer. Cancer Treat. Rev. 2014, 40(10):1153-1160.
173. 2+-dependent manner. Proc. Natl. Acad. Sci. U. S. A. 2015, 112(6):2-7.
174. Giorgi C., Bonora M., Pinton P. Inside the tumor: p53 modulates calcium homeostasis. Cell Cycle 2015, 14(7):933-934.
175. Giorgi C., Bonora M., Missiroli S., Poletti F., Ramirez F.G., Morciano G., Morganti C., Pandolfi P.P., Mammano F., Pinton P. Intravital imaging reveals p53-dependent cancer cell death induced by phototherapy via calcium signaling. Oncotarget 2015, 6(3):1435-1445.
176. Bonora M., Giorgi C., Pinton P. Novel frontiers in calcium signaling: a possible target for chemotherapy. Pharmacol. Res. 2015, 99:82-85.
177. 2+ signaling from the endoplasmic reticulum: partners in anti-cancer therapies. Oncoscience 2015, 2(3):233-238.
178. Karnoub A.E., Weinberg R.A. Ras oncogenes: split personalities. Nat. Rev. Mol. Cell Biol. 2008, 9:517-531.
179. Schubbert S., Shannon K., Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat. Rev. Cancer 2007, 7:295-308.
180. Schmukler E., Kloog Y., Kramarski R.P. Ras and autophagy in cancer development and therapy. Oncotarget 2014, 5(3):577-586.
181. 2+ influx in voltage-clamped ras-transformed NIH/3 T3 fibroblasts. J. Biol. Chem. 1993, 268(26):19403-19410.
182. Song C., Hu C.D., Masago M., Kariya K.I., Yamawaki-Kataoka Y., Shibatohge M., Wu D., Satoh T., Kataoka T. Regulation of a novel human phospholipase C, PLCepsilon, through membrane targeting by ras. J. Biol. Chem. 2001, 276(4):2752-2757.
183. Bunney T.D., Harris R., Gandarillas N.L., Josephs M.B., Roe S.M., Sorli S.C., Paterson H.F., Rodrigues-Lima F., Esposito D., Ponting C.P., Gierschik P., Pearl L.H., Driscoll P.C., Katan M. Structural and mechanistic insights into ras association domains of phospholipase C epsilon. Mol. Cell 2006, 21(4):495-507.
184. 2+ levels in colorectal cancer cell lines. J. Cell Sci. 2014, 127:1607-1619.
185. Bivona T.G., Quatela S.E., Bodemann B.O., Ahearn I.M., Soskis M.J., Mor A., Miura J., Wiener H.H., Wright L., Saba S.G., Yim D., Fein A., Pérez de Castro I., Li C., Thompson C.B., Cox A.D., Philips M.R. PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis. Mol. Cell 2006, 21(4):481-493.
186. Sung P.J., Tsai F.D., Vais H., Court H., Yang J., Fehrenbacher N., Foskett J.K., Philips M.R. Phosphorylated K-Ras limits cell survival by blocking Bcl-xL sensitization of inositol trisphosphate receptors. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(51):20593-20598.
187. Rimessi A., Marchi S., Patergnani S., Pinton P. H-Ras-driven tumoral maintenance is sustained through caveolin-1-dependent alterations in calcium signaling. Oncogene 2014, 33(18):2329-2340.